BEAM logo

Beam Therapeutics (BEAM) Company Overview

Profile

Full Name:

Beam Therapeutics Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

February 6, 2020

Indexes:

Not included

Description:

Beam Therapeutics is a biotechnology company focused on developing precision genetic medicines using its proprietary base editing technology. This innovative approach allows for precise modifications to DNA, aiming to treat various genetic diseases and improve patient outcomes through targeted therapies.

Key Details

Price

$27.15

Annual Revenue

$63.52 M(-83.18% YoY)

Annual EPS

-$4.58(-166.28% YoY)

Annual ROE

-43.94%

Beta

1.89

Events Calendar

Earnings

Next earnings date:

May 7, 2025

Recent quarterly earnings:

Feb 25, 2025

Recent annual earnings:

Feb 25, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 26, 25 RBC Capital
Sector Perform
Feb 3, 25 HC Wainwright & Co.
Buy
Jan 29, 25 Cantor Fitzgerald
Overweight
Dec 9, 24 HC Wainwright & Co.
Buy
Nov 7, 24 HC Wainwright & Co.
Buy
Nov 6, 24 RBC Capital
Sector Perform
Nov 6, 24 Leerink Partners
Outperform
Oct 16, 24 Scotiabank
Sector Perform
Sep 19, 24 RBC Capital
Sector Perform
Sep 17, 24 Jones Trading
Hold

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Beam Therapeutics?
  • Does Beam Therapeutics pay dividends?
  • What sector is Beam Therapeutics in?
  • What industry is Beam Therapeutics in?
  • What country is Beam Therapeutics based in?
  • When did Beam Therapeutics go public?
  • Is Beam Therapeutics in the S&P 500?
  • Is Beam Therapeutics in the NASDAQ 100?
  • Is Beam Therapeutics in the Dow Jones?
  • When was Beam Therapeutics's last earnings report?
  • When does Beam Therapeutics report earnings?
  • Should I buy Beam Therapeutics stock now?

What is the ticker symbol for Beam Therapeutics?

The ticker symbol for Beam Therapeutics is NASDAQ:BEAM

Does Beam Therapeutics pay dividends?

No, Beam Therapeutics does not pay dividends

What sector is Beam Therapeutics in?

Beam Therapeutics is in the Healthcare sector

What industry is Beam Therapeutics in?

Beam Therapeutics is in the Biotechnology industry

What country is Beam Therapeutics based in?

Beam Therapeutics is headquartered in United States

When did Beam Therapeutics go public?

Beam Therapeutics's initial public offering (IPO) was on February 6, 2020

Is Beam Therapeutics in the S&P 500?

No, Beam Therapeutics is not included in the S&P 500 index

Is Beam Therapeutics in the NASDAQ 100?

No, Beam Therapeutics is not included in the NASDAQ 100 index

Is Beam Therapeutics in the Dow Jones?

No, Beam Therapeutics is not included in the Dow Jones index

When was Beam Therapeutics's last earnings report?

Beam Therapeutics's most recent earnings report was on Feb 25, 2025

When does Beam Therapeutics report earnings?

The next expected earnings date for Beam Therapeutics is May 7, 2025

Should I buy Beam Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions